2.24
price up icon1.82%   0.04
after-market Handel nachbörslich: 2.25 0.010 +0.45%
loading

Ensysce Biosciences Inc Aktie (ENSC) Neueste Nachrichten

pulisher
09:16 AM

Has Ensysce Biosciences Inc. Stock Ever Crashed Historical Volatility ReviewTop Performing Stocks - Newser

09:16 AM
pulisher
09:01 AM

Why is Ensysce Biosciences Inc. stock attracting strong analyst attentionAccess exclusive market insights for free - jammulinksnews.com

09:01 AM
pulisher
07:51 AM

Why Ensysce Biosciences Inc. stock attracts strong analyst attentionFree Top Growth Stock Recommendations - Newser

07:51 AM
pulisher
07:37 AM

How volatile is Ensysce Biosciences Inc. stock compared to the marketStay ahead with advanced stock screening tools - jammulinksnews.com

07:37 AM
pulisher
Jul 25, 2025

Is Ensysce Biosciences Inc. a good long term investmentHigh-yield investments - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Ensysce Biosciences Inc. stock priceExponential wealth increase - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

Published on: 2025-07-25 08:23:29 - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Ensysce Biosciences Inc. stockHigh-performance investment picks - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

When (ENSC) Moves Investors should Listen - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 22, 2025

Ensysce Biosciences Inc. Stock Analysis and ForecastUnprecedented profits - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

Ensysce Biosciences initiates Phase 3 study of PF614 - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

FDA-Reviewed Phase 3 Trial Begins: Revolutionary Opioid Promises Pain Relief Without Abuse Risk - Stock Titan

Jul 16, 2025
pulisher
Jul 16, 2025

Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614A Next-Generation OpioidDesigned to Deliver Powerful Pain Relief and Reduce Abuse - The Globe and Mail

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Ensysce Biosciences Inc. stock price move sharplySolid Return Trade Selections - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Ensysce Biosciences Inc. stock performs during market volatilityHigh Yield Stock Selection - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

NAVY(boat pilot token) Tokenomics ExplainedHigh Return Potential - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Where are the Opportunities in (ENSC) - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 08, 2025

Travere Therapeutics (NASDAQ:TVTX) and Ensysce Biosciences (NASDAQ:ENSC) Head to Head Comparison - Defense World

Jul 08, 2025
pulisher
Jun 24, 2025

FDA-Designated Breakthrough Pain Drug Advances: New Solution to Opioid Overdose Crisis Shows Promise - Stock Titan

Jun 24, 2025
pulisher
Jun 21, 2025

(ENSC) Investment Analysis - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 15, 2025

Short Interest in Ensysce Biosciences, Inc. (NASDAQ:ENSC) Declines By 71.5% - Defense World

Jun 15, 2025
pulisher
Jun 11, 2025

Leading Pain Experts Reveal New Opioid Abuse Prevention Technology at World's Largest Pain Conference - Stock Titan

Jun 11, 2025
pulisher
Jun 11, 2025

(ENSC) On The My Stocks Page - news.stocktradersdaily.com

Jun 11, 2025
pulisher
Jun 07, 2025

Ensysce Biosciences (NASDAQ:ENSC) Trading 1.7% Higher – Here’s What Happened - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

ensysce biosciences appoints baker tilly as new auditor By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

ensysce biosciences appoints baker tilly as new auditor - Investing.com

Jun 05, 2025
pulisher
Jun 04, 2025

Ensysce Flat on Receiving Grant - Baystreet.ca

Jun 04, 2025
pulisher
Jun 04, 2025

Ensysce Biosciences secures additional $5.3M NIDA grant - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

Ensysce Biosciences secures additional $5.3M NIDA grant By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

Ensysce Biosciences (ENSC) Secures $5.3M Grant to Advance Opioid Development | ENSC Stock News - GuruFocus

Jun 04, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):